Activity of the proteolytic enzyme guanidinobenzoatase in human basal cell carcinoma.

ORL; Journal for Oto-rhino-laryngology and Its Related Specialties
F S StevenH Weidauer

Abstract

Basal cell carcinomas exhibit a characteristic pattern of aggressive invasion from the basal layer of skin epithelial cells. These tumour cells possess an enzyme, guanidinobenzoatase (GB), which is known to be associated with cell migration. The enzyme is inhibited by a fluorescent probe, 9-aminoacridine, and this can be used to locate cells possessing active guanidinobenzoatase. All basal cell carcinoma cells in frozen sections were located by their ability to bind 9-aminoacridine. Extracts of most tissues were shown to contain inhibitors of the GB associated with basal cell carcinoma cells. Extracts of skin, however, failed to inhibit this tumour-associated GB. The significance of these results is discussed in terms of the pathophysiology of basal cell carcinomas.

Citations

Nov 30, 2002·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Yan HeEdward S Yeung

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Carcinoma, Basal Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.